AMED (Japan Agency for Medical R&D) logo
Funder · Federal agency

AMED (Japan Agency for Medical R&D)

Funds medical research in Japan across drug discovery, devices, regenerative therapies, and healthcare innovation from early studies to development.

Japanwww.amed.go.jp
Key stats
Annual funding—
Programs9
Active grants1
Total grants1
About

Japan Agency for Medical Research and Development (AMED) is Japan's national medical R&D agency, established on April 1, 2015 and based in Tokyo. The agency sits under the national government and is overseen by the Prime Minister together with MEXT, MHLW, and METI. Its FY 2026 budget is JPY 116.9 billion, and it employed 791 full-time staff as of April 1, 2026.

AMED's remit spans nine major resea…

Programs & grants under this funder
Advanced Research & Development Programs for Medical Innovation (AMED-CREST / PRIME / LEAP)

Backs researchers and academic institutions through Advanced Medical Innovation, helping them access seed funding for medical breakthroughs.

Drug Discovery Support Network (DDSN)

Provides cutting-edge screening and optimization technologies across drug modalities through three research organizations.

iD3 Technology Archive

Connects companies with pioneering drug-discovery technologies developed by universities and research institutions.

Infrastructure Program for Drug Discovery Seeds Development

Provides researchers and academic institutions through Drug Discovery Seeds Infrastructure, helping them build shared discovery ecosystems.

Innovative Drug Discovery and Development

Funds research from drug discovery through clinical trials across eight sub-programs and modality platforms.

Strengthening Program for Pharmaceutical Startup Ecosystem

Funds pharmaceutical startups in Japan through development stages with registered venture capital investment.

1 grant
Strengthening Program for Pharmaceutical Startup Ecosystem
Open
— pool
AMED Cyclic Innovation for Clinical Empowerment (CiCLE)

Funds AMED Cyclic Innovation for Clinical Empowerment for late-stage clinical translation in medicine and healthcare devices.

AMED J-Bridge — Japan Bridges Industry-Academia

Runs AMED J-Bridge to connect industry and academia in international medical research collaborations and shared development activity.

AMED Translational Research Grant (TR program)

Supports AMED Translational Research programs helping move medical discoveries into practical medicine, device, and therapy development.

Last verified: 17 May 2026Source: www.amed.go.jp